Colleen Jay Net Worth

The estimated Net Worth of Colleen Jay is at least 3.36 百万$ dollars as of 1 April 2024. Ms. Jay owns over 2,892 units of Cooper Companies stock worth over 2,908,068$ and over the last 9 years she sold COO stock worth over 0$. In addition, she makes 448,462$ as Independent Director at Cooper Companies.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Jay COO stock SEC Form 4 insiders trading

Colleen has made over 7 trades of the Cooper Companies stock since 2018, according to the Form 4 filled with the SEC. Most recently she exercised 2,892 units of COO stock worth 313,811$ on 1 April 2024.

The largest trade she's ever made was exercising 2,892 units of Cooper Companies stock on 1 April 2024 worth over 313,811$. On average, Colleen trades about 482 units every 123 days since 2016. As of 1 April 2024 she still owns at least 26,800 units of Cooper Companies stock.

You can see the complete history of Ms. Jay stock trades at the bottom of the page.

Colleen Jay biography

Colleen E. Jay is Independent Director of the Company. Ms. Jay served as a Global Division President for Procter and Gamble until her retirement in October 2017. Her most recent operational assignment was President, Global Beauty Specialty Business at Procter & Gamble from 2015 where she was responsible for the Wella Professional Salon, Cosmetics, Retail Hair Color, and Fragrance businesses, and the successful divestiture of them. Prior to that, Ms. Jay led the multi-billion dollar Global Retail Hair Care and Color division of Procter & Gamble from 2012 to 2015 and the Global Female Beauty division from 2010 to 2012. She also served as Vice President & General Manager, Greater China Feminine Care, Personal Cleansing, Oral Care & Entire China Marketing Function, based in Guangzhou, China, from 2006 to 2009, where she was responsible for businesses with a combined value of over $1 Billion. She has worked in various positions with Procter & Gamble since July 1985 and has led operational units in the United States, Canada, China, and Switzerland (including leading global businesses) during the course of her career. Ms. Jay has also volunteered at Catalyst, Inc., a non-profit organization dedicated to improving workplace inclusion for women.

What is the salary of Colleen Jay?

As the Independent Director of Cooper Companies, the total compensation of Colleen Jay at Cooper Companies is 448,462$. There are 13 executives at Cooper Companies getting paid more, with Albert White having the highest compensation of 7,724,740$.

How old is Colleen Jay?

Colleen Jay is 57, she's been the Independent Director of Cooper Companies since 2016. There are 8 older and 10 younger executives at Cooper Companies. The oldest executive at Cooper Companies, Inc. is A. Thomas Bender, 80, who is the Independent Chairman of the Board.

What's Colleen Jay's mailing address?

Colleen's mailing address filed with the SEC is C/O BEYOND MEAT, INC., 888 N. DOUGLAS STREET, SUITE 100, EL SEGUNDO, CA, 90245.

Insiders trading at Cooper Companies

Over the last 21 years, insiders at Cooper Companies have traded over 45,273,696$ worth of Cooper Companies stock and bought 5,157 units worth 1,262,486$ . The most active insiders traders include Robert S Weiss、William A Kozy、Lawrence Erik Kurzius. On average, Cooper Companies executives and independent directors trade stock every 18 days with the average trade being worth of 1,325,775$. The most recent stock trade was executed by Brian G Andrews on 5 September 2024, trading 24,788 units of COO stock currently worth 939,713$.

What does Cooper Companies do?

company overview the cooper companies, inc. ("cooper"​) is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.

Complete history of Ms. Jay stock trades at Cooper Companies、Beyond Meat Inc

Cooper Companies executives and stock owners

Cooper Companies executives and other stock owners filed with the SEC include:

• Albert White,
  President, Chief Executive Officer, Director
• Daniel McBride,
  Chief Operating Officer, Executive Vice President, President of CooperVision, Inc.
• Holly Sheffield,
  President - CooperSurgical
• Brian Andrews,
  Chief Financial Officer, Senior Vice President, Treasurer
• Albert G. White III,
  Pres, CEO & Non-Independent Director
• Agostino Ricupati,
  Senior Vice President - Finance and Tax, Chief Accounting Officer
• Daniel G. McBride Esq.,
  Exec. VP & COO
• Holly R. Sheffield,
  Pres of CooperSurgical, Inc.
• Brian G. Andrews,
  Exec. VP, CFO & Treasurer
• A. Thomas Bender,
  Independent Chairman of the Board
• Allan Rubenstein,
  Independent Vice Chairman of the Board, Lead Director
• Jody Lindell,
  Independent Director
• Gary Petersmeyer,
  Independent Director
• Colleen Jay,
  Independent Director
• William Kozy,
  Independent Director
• Robert Weiss,
  Director
• Teresa Madden,
  Independent Director
• Kim Duncan,
  Vice President of Investor Relations and Administration
• Randal Golden,
  Vice President, General Counsel, Secretary
• Juan Carlos Aragón,
  Pres of CooperVision Specialty EyeCare Division
• Mark J. Drury,
  VP, Gen. Counsel & Corp. Sec.
• Agostino Ricupati,
  Sr. VP of Fin. & Tax and Chief Accounting Officer
• Carol R Kaufman,
  VP Legal Affairs, Sec. and CAO
• Paul L Remmell,
  COO, VP Finance-CSI
• Tina Maloney,
  Corporate Controller
• Gregory W Matz,
  VP & CFO
• Stanley Md Zinberg,
  Director
• Michael Kalkstein,
  
• Nicholas J Pichotta,
  
• Rodney Folden,
  Corporate Controller
• Donald Press,
  Director
• Steven Rosenberg,
  Director
• Jeffrey Alan Mc Lean,
  Pres - U.S. Ops - CVI
• Dennis Murphy,
  President Americas, CVI
• Moses Marx,
  Director
• Andrew Sedgwick,
  Managing Dir., Europe of CVI
• Eugene J Midlock,
  Vice President, Taxes
• John J Calcagno,
  CFO and VP Bus. Dev.
• John Arthur Weber,
  Vice Pres Worldwide Ops-CVI
• J Christopher Marmo,
  VP, R&D of CooperVision, Inc.
• John D Fruth,
  Director
• B Norris Battin,
  
• Edgar J Cummins,
  Director
• Steven M Neil,
  CFO
• David Acosta,
  Treasurer
• Companies Inc Cooper,
  Director
• Gregory A Fryling,
  COO - CVI
• James M Welch,
  Vice President Intl Ops - CVI
• Stephen Whiteford,
  VP, Corporate Controller
• Robert D Auerbach,
  Special Advisor to the CEO
• Mark J Drury,
  VP, General Counsel & Sec.
• Maria Rivas,
  
• Gerard H Iii Warner,
  President, CooperVision, Inc.
• Nicholas Khadder,
  VP, General Counsel & Corp Sec
• Lawrence Erik Kurzius,
  
• Cynthia L Lucchese,